JONES EVAN/ FA 4

What Happened

• Evan Jones, a director of Veracyte, was granted 5,272 restricted stock units (RSUs) on June 11, 2026. The reported acquisition price is $0.00, so the filing shows $0 cash paid for the award. This was an equity award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-11; Filing date: 2026-06-15 (filed within the two-business-day Form 4 deadline).
• Grant: 5,272 RSUs at $0.00 per share (total reported value $0 on the Form 4).
• Shares owned after transaction: not specified in the provided filing details.
• Footnote: RSUs vest in full on the first anniversary of the grant or immediately prior to the company’s next annual meeting if earlier; vest in full upon a change in control of the company.
• No tax-withholding or sale reported in this filing.

Context

• RSU awards are a form of compensation for directors and typically vest over time or on certain events; they do not represent immediately marketable shares until vesting occurs. This grant is routine compensation and does not by itself indicate buying or selling sentiment. The change-in-control vesting provision can accelerate vesting in the event of a takeover.